Startseite UR

Einträge von Zhang, Shanshan auf dem Publikationsserver

Eine Stufe nach oben
Exportieren als
[feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Gruppieren nach: Datum | Dokumentenart | Keine Gruppierung
Gehe zu: 2022 | 2021 | 2018 | 2017 | 2016
Anzahl der Einträge: 7.

2022

Cigliano, Antonio, Zhang, Shanshan, Ribback, Silvia, Steinmann, Sara, Sini, Marcella, Ament, Cindy E., Utpatel, Kirsten, Song, Xinhua, Wang, Jingxiao , Pilo, Maria G., Berger, Fabian, Wang, Haichuan , Tao, Junyan, Li, Xiaolei, Pes, Giovanni M. , Mancarella, Serena, Giannelli, Gianluigi, Dombrowski, Frank, Evert, Matthias, Calvisi, Diego F., Chen, Xin und Evert, Katja (2022) The Hippo pathway effector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease. Journal of Experimental & Clinical Cancer Research 41, art.no.192.

Wang, Haichuan, Zhang, Shanshan, Zhang, Yi, Jia, Jiaoyuan, Wang, Jingxiao, Liu, Xianqiong, Zhang, Jie, Song, Xinhua, Ribback, Silvia, Cigliano, Antonio, Evert, Matthias, Liang, Bingyong, Wu, Hong, Calvisi, Diego F., Zeng, Yong und Chen, Xin (2022) TAZ is indispensable for c-MYC-induced hepatocarcinogenesis. Journal of Hepatology 76 (1), S. 123-134. Volltext nicht vorhanden.

2021

Wang, Haichuan , Wang, Jingxiao , Zhang, Shanshan, Jia, Jiaoyuan, Liu, Xianqiong, Zhang, Jie, Wang, Pan , Song, Xinhua, Che, Li, Liu, Ke, Ribback, Silvia, Cigliano, Antonio , Evert, Matthias, Wu, Hong, Calvisi, Diego F., Zeng, Yong und Chen, Xin (2021) Distinct and Overlapping Roles of Hippo Effectors YAP and TAZ During Human and Mouse Hepatocarcinogenesis. Cellular and Molecular Gastroenterology and Hepatology 11 (4), S. 1095-1117. Volltext nicht vorhanden.

2018

Song, Xinhua, Liu, Xianqiong, Wang, Haichuan , Wang, Jingxiao , Qiao, Yu, Cigliano, Antonio, Utpatel, Kirsten, Ribback, Silvia, Pilo, Maria G., Serra, Marina, Gordan, John D., Che, Li, Zhang, Shanshan, Cossu, Antonio, Porcu, Alberto, Pascale, Rosa M., Dombrowski, Frank, Hu, Hongbo, Calvisi, Diego F., Evert, Matthias und Chen, Xin (2018) Combined CDK4/6 and Pan-mTOR Inhibition Is Synergistic Against Intrahepatic Cholangiocarcinoma. Clinical Cancer Research 25 (1), S. 403-413. Volltext nicht vorhanden.

Dong, Mingjie, Liu, Xianqiong, Evert, Katja, Utpatel, Kirsten, Peters, Michele, Zhang, Shanshan, Xu, Zhong, Che, Li, Cigliano, Antonio , Ribback, Silvia, Dombrowski, Frank, Cossu, Antonio, Gordan, John, Calvisi, Diego F., Evert, Matthias, Liu, Yan und Chen, Xin (2018) Efficacy of MEK inhibition in a K-Ras-driven cholangiocarcinoma preclinical model. Cell Death & Disease 9 (2). Volltext nicht vorhanden.

2017

Zhang, Shanshan, Song, Xinhua, Cao, Dan, Xu, Zhong, Fan, Biao, Che, Li, Hu, Junjie, Chen, Bin, Dong, Mingjie, Pilo, Maria G., Cigliano, Antonio , Evert, Katja, Ribback, Silvia, Dombrowski, Frank, Pascale, Rosa M., Cossu, Antonio, Vidili, Gianpaolo, Porcu, Alberto, Simile, Maria M., Pes, Giovanni M., Giannelli, Gianluigi, Gordan, John, Wei, Lixin, Evert, Matthias, Cong, Wenming, Calvisi, Diego F. und Chen, Xin (2017) Pan-mTOR inhibitor MLN0128 is effective against intrahepatic cholangiocarcinoma in mice. Journal of Hepatology 67 (6), S. 1194-1203. Volltext nicht vorhanden.

2016

Wang, Chunmei, Che, Li, Hu, Junjie, Zhang, Shanshan, Jiang, Lijie, Latte, Gavinella , Demartis, Maria I., Tao, Junyan, Gui, Bing, Pilo, Maria G., Ribback, Silvia, Dombrowski, Frank, Evert, Matthias, Calvisi, Diego F. und Chen, Xin (2016) Activated mutant forms of PIK3CA cooperate with RasV12 or c-Met to induce liver tumour formation in mice via AKT2/mTORC1 cascade. Liver International 36 (8), S. 1176-1186. Volltext nicht vorhanden.

Diese Liste wurde erzeugt am Sat Dec 21 19:28:06 2024 CET.
  1. Universität

Universitätsbibliothek

Publikationsserver

Kontakt:

Publizieren: oa@ur.de
0941 943 -4239 oder -69394

Dissertationen: dissertationen@ur.de
0941 943 -3904

Forschungsdaten: datahub@ur.de
0941 943 -5707

Ansprechpartner